Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy
Status:
Unknown status
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
Hepatic encephalopathy is a syndrome occurs in patients with liver cirrhosis and is defined
as neuropsychiatric abnormalities in patients with liver impairment, characterized by
personality changes, intellectual impairment, and an impaired level of consciousness.
Coenzyme Q10 (CoQ10) is a necessary cofactor of the mitochondrial metabolism. It provides a
High antioxidant and protective effects on age-related morbidities such as hypertension,
heart failure and neurodegenerative diseases and hepatoprotective effects in drug related
hepatic impairment.
Meclofenoxate is a cholinergic nootropic drug used clinically to improve memory, mental
function and general cognition.